Inga-Lill is the head of the Stockholm office and EIP’s practice in Sweden. She is a highly experienced European and Swedish patent attorney, having her expertise within chemistry and life sciences.
Before joining EIP in 2022, Inga-Lill worked at AWA for more than two decades. Inga-Lill has handled all types of patent-related issues, including drafting and prosecution of patent applications, freedom-to-operate analyses, and due diligence investigations. She has also been deeply involved in patent litigation cases before Swedish courts. Inga-Lill is well placed to advise clients on the Unified Patent Court (UPC).
Her excellent work has been recognised and she has been listed as a Patent Star by Managing Intellectual Property, as a recommended individual for prosecution in the IAM Patent 1000: The World’s Leading Patent Professionals, and as a WIPR Leader. She has also been listed as one of the ‘Top 250 Women in IP’ and has been recognised in "WIPR Influential women in IP".
Inga-Lill also has extensive leadership and management experience. For six years, she held the role as a Business Area Manager, AWA North Sweden, and was also a member of the Swedish management team. She has experience of expansion into new markets and has been heavily engaged in the establishment of a new office.
Inga-Lill holds a Master’s degree in Chemical Engineering specializing in Biotechnology from Chalmers University of Technology in Sweden. She also received CEIPI Diploma in European Patent Litigation from Strasbourg University in 2015.
Education
- 2015 European Patent Litigation Certificate
-
1994 — 2000
M.Sc. Chemical Engineering, Chalmers University of Technology, Sweden
Career history
- 2022 — present
Partner, EIP - 2016 — 2022
Business Area Manager, North Sweden, AWA - 2015 — 2016
Team Manager, Chemistry, North Sweden, AWA - 2006 — 2015
European Patent Attorney, AWA - 2000 — 2006
Patent Attorney, AWA - 1998 — 1999
Analytical Chemist, AstraZeneca
Awards and recognition
- Ranked as 'Patent Star 2025' IP Stars (link)
- WIPR Leaders 2025: Recognised individual (link)
- WIPR Leaders 2024: Recognised individual (link)
- IAM Patent 1000 2024 (link)
- Ranked as 'Patent Star 2024' IP Stars (link)
- WIPR Leader 2023, Patent Leaders (link)
- Ranked as a 'Patent Star', IP Stars 2023
- Ranked as a "Patent Star", IP Star 2022
- Recommended IAM Patent 1000, 2022
- Ranked as ‘a WIPR Leader’, World IP Review 2022
- Ranked as a "Patent Star", IP Star 2021
- Ranked as ‘a WIPR Leader’, World IP Review 2021
- Recommended IAM Patent 1000, 2021
- Ranked as ‘a WIPR Leader’, World IP Review 2020
- Recommended IAM Patent 1000, 2020
- Ranked as a "Patent Star", IP Star 2020
- Ranked as ‘a WIPR Leader’, World IP Review 2019
- Ranked as WIPR Influential Women in IP, 2019
- Recommended IAM Patent 1000, 2019
- Ranked as a "Patent Star", IP Star 2019
- Ranked as a "Top 250 Women in IP", IP Star 2018
- Ranked in Legal Media Group's Patent Expert Guide, 2018
- Ranked as ‘a WIPR Leader’, World IP Review 2018
- Ranked as a "Patent Star", IP Star 2017
- Ranked in Legal Media Group's Patent Expert Guide, 2017
- Ranked in Legal Media Group's Patent Expert Guide, 2017
- Ranked as a ‘WIPR Leader’, World IP Review 2017
- Recommended IAM Patent 1000, 2017
- Ranked as a "Patent Star", IP Star 2016
- Ranked in Legal Media Group's Patent Expert Guide, 2016
- Ranked as a ‘WIPR Leader’, World IP Review 2016
- Recommended IAM Patent 1000, 2016
- Ranked as a "Patent Star", IP Star 2015
- Ranked in Legal Media Group's Patent Expert Guide, 2015
- Recommended IAM Patent 1000, 2015
- Ranked as a "Patent Star", IP Star 2014
- Recommended IAM Patent 1000, 2014
- Recommended IAM Patent 1000, 2013
Languages spoken
- Swedish (Native)
- English (Fluent)
Additional information
- Board Member of SEPAF (The Association of Intellectual Property Law in Sweden) 2017-2020
Specialisms
Digital
- Digital health
Elements
- Food & flavour ingredients
- Pharmaceuticals
HealthTech
- Digital health
- Femtech
- Medical devices
- Personalised healthcare
- Surgical tools and implants
Life
- Agritech
- Biologics
- Biotech
- Cell therapy
- Gene editing
- Immunotherapy
- Microbiome
- Pharmaceuticals